|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/425 | |
| A61P 35/00 | |||
| A61K 31/4745 | |||
| A61K 31/505 | |||
| A61K 31/282 | |||
| A61K 31/337 | |||
| A61K 31/70 |
| (11) | Number of the document | 1545519 |
| (13) | Kind of document | T |
| (96) | European patent application number | 03792573.2 |
| Date of filing the European patent application | 2003-08-07 | |
| (97) | Date of publication of the European application | 2005-06-29 |
| (45) | Date of publication and mention of the grant of the patent | 2011-03-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2003/003550 |
| Date | 2003-08-07 |
| (87) | Number | WO 2004/017964 |
| Date | 2004-03-04 |
| (30) | Number | Date | Country code |
| 404461 P | 2002-08-19 | US |
| (72) |
BEEBE, Jean, Saccuzzo, US
FERRANTE, Karen, Jean, US
JANI, Jitesh, Pranlal, US
SCHAEFFER, Tracey, Lee, US
HEALEY, Diane, Ingeborg, US
O`LEARY, James, John, US
|
| (73) |
OSI Pharmaceuticals, Inc.,
41 Pinelawn Road, Melville, NY 11747,
US
Pfizer Inc., 235 East 42nd Street, New York, NY 10017-5755, US |
| (54) | COMBINATION THERAPY FOR HYPERPROLIFERATIVE DISEASES |
| COMBINATION THERAPY FOR HYPERPROLIFERATIVE DISEASES |